发明授权
- 专利标题: Oral dosage form comprising an antimisuse system
- 专利标题(中): 包含抗炎系统的口服剂型
-
申请号: US11651577申请日: 2007-01-10
-
公开(公告)号: US08895063B2公开(公告)日: 2014-11-25
- 发明人: Florence Guimberteau , Frederic Dargelas , Gérard Soula , Rémi Soula
- 申请人: Florence Guimberteau , Frederic Dargelas , Gérard Soula , Rémi Soula
- 申请人地址: FR Venissieux
- 专利权人: Flamel Technologies
- 当前专利权人: Flamel Technologies
- 当前专利权人地址: FR Venissieux
- 代理机构: Porzio, Bromberg & Newman P.C.
- 主分类号: A61K8/20
- IPC分类号: A61K8/20 ; A61K9/50 ; A61K45/06 ; A61K33/30 ; A61K33/26 ; A61K33/06 ; A61K9/48
摘要:
An oral solid dosage form containing one or several active principle(s) having analgesic properties, the composition of said dosage form being such that it prevents the misuse of said dosage form through the liquid extraction of the active principle(s) contained therein, using commonly available solvents.Said oral solid dosage form containing at least one salt of at least one analgesic active principle, and an anti-misuse system comprising at least one quenching agent, said quenching agent being suitable for inducing complexation of said analgesic active principle salt when the analgesic active principle salt is improperly extracted, notably by a drug abuser, in vitro in solution from said oral solid dosage form.
公开/授权文献
- US20080008659A1 Oral dosage form comprising an antimisuse system 公开/授权日:2008-01-10
信息查询